Transo-Pharm.com - Transo-Pharm Blog

CPHI China 2025

5/8/2025

This year's CPHI China will take place in Shanghai from June 24 to 26, 2025. We are looking forward to meeting our partners in person at this important event.
This year Jessica Ha, Frank Krause and Xiding Geng from the Transo-Pharm team will be attending.
Please contact Jessica Ha to arrange a meeting.

See you in Shanghai!
Transo-Pharm, your connecting link.

Transo-Pharm Epinephrine (Adrenaline) Approved in China

5/6/2025

We are excited to share that our Epinephrine (Adrenaline) API has received DMF (Drug Master File) approval from the NMPA (National Medical Products Administration) in China. The approval (#Y20190000447) was officially published on the CDE (Center for Drug Evaluation) website on April 16, 2025.
With this important milestone, Transo-Pharm is ready to fully support clients planning to launch formulations containing our Epinephrine API in the Chinese market.
For more information or support, please contact our Product Manager, Jessica Ha, at [email protected].

Welcome to DCAT / New York in March 2025

2/24/2025

Having business meetings above the roofs of New York is truly unique and set themselves apart from the exhibition hall atmosphere we are used to at other trade shows. For more details click here: DCAT Week 2025

Transo-Pharm's German-American team is looking forward to meeting our customers and partners at this year’s DCAT in New York, which will take place from March 17-20. As in previous years, Transo-Pharm will welcome you at the Lotte Hotel New York Palace.

If you wish to make an appointment you may contact us via [email protected]

Season's Greetings

12/4/2024

The Transo-Pharm Christmas Tree is up and decorated.

The history of Christmas trees has many roots, ranging from the use of evergreens in ancient Egypt and Rome to the German traditions of candlelit trees that made its way to America in the 1800s.
In many countries it was believed that evergreens would keep away witches, ghosts, evil spirits, and illness.

In this sense, we and our little guy wish you all a peaceful and joyful Holiday Season!

... next stop Frankfurt

10/29/2024

It has been three weeks now since the pharma world met in Milan for the CPHI 2024.

Three intensive days in this beautiful city were worth the efforts as they brought a lot of ideas to light, which we are now working on.

The whole Transo-Pharm team enjoyed meeting up with our friends and partners – be it at a table at the Transo-Pharm booth or during our Happy Hour event with a glass of wine in our hands.

We are already looking forward to seeing you all again in Frankfurt in 2025.

Epinephrine

10/1/2024

Over a decade has passed since we acquired the Epinephrine (Adrenaline) business from Boehringer Ingelheim. At Transo-Pharm, we didn’t just take over the business — we made a commitment to ensuring a secure supply chain for our customers. We've gone even further by integrating upstream to become less dependent on external suppliers for starting materials. Throughout the transition, we consistently provided bridging stock on time and streamlined the regulatory process for our valued partners.

Discover the incredible journey we've been on...

CPHI Milan 2024

9/16/2024

CPHI will take place again in Milan and the Transo-Pharm sales team is looking forward to exhibiting at one of the most important pharmaceutical trade fairs from October 8-10, 2024.

The following Transo-Pharm partners will also be represented personally at our booth: allegropharm GmbH, Alven Laboratories s.r.o., Carinopharm GmbH, Kemimac (S) PTE LTD, Chiracon GmbH, Hapila GmbH, Vitalchemie Corporation.

If you would like to attend the show and speak to us in person, please do not hesitate to contact us.
We look forward to connecting with partners and industry experts and creating new synergies.

For Transo-Pharm appointments please contact [email protected]

tph_product_list_cphi_2024.pdf
File Size:	174 kb
File Type:	pdf

Transo-Pharm becomes green...or blue?

8/19/2024

Colleagues have been finding their way to work on their newly purchased JobRad bicycles for several months now. However, the associated CO2 savings are not enough for us. Transo-Pharm has set itself the goal of further minimizing its CO2 footprint.

For this reason, the first fully electric vehicles can now be found in our fleet - more will follow. Consequently, we have installed eight wall boxes on our company premises with which colleagues can easily charge their vehicles.

Transo-Pharm has also invested in its own photovoltaic system to cover its own operational electricity consumption.
With these steps we are gradually working to become greener - for our environment.

Transo-Pharm Expands Portfolio - Welcome on board, Norepinephrine Bitartrate

7/29/2024

Epinephrine Base and Epinephrine Bitartrate have been in our portfolio even before we acquired the IP from the originator Boehringer Ingelheim. Over the last couple of years our customers have expressed their need for Norepinephrine Bitartrate and we listened.

We have proudly partnered up with hameln rds s.r.o. a Slovakian based API producer who has developed a robust Norepinephrine production process. The CEP has been issued by EDQM July 26, 2024. In this partnership, Transo-Pharm will focus on all commercial aspects and hameln rds will concentrate on production and quality.

In memory of Artan "Tani" Bekteshi

6/27/2024

We're saddened to hear about the passing of our long-time team member Artan "Tani" Bekteshi. Tani has been taking care of our warehousing and logistics for 20 years. He did this with extreme devotion and an outstanding perfection.

He will be immensely missed.

Our hearts and thoughts are with his family.